MLchartDataset catalogue

sargramostim plasmid DNA melanoma vaccine adjuvant

Term · Oncology and biomedicine · MLC-T-ONC-016645

A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.

Table 1. Record
IdentifierMLC-T-ONC-016645
FieldOncology and biomedicine
SynonymsGM-CSF plasmid DNA melanoma vaccine adjuvant
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016645",
  "term": "sargramostim plasmid DNA melanoma vaccine adjuvant",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.",
  "synonyms": [
    "GM-CSF plasmid DNA melanoma vaccine adjuvant"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/sargramostim-plasmid-dna-melanoma-vaccine-adjuvant/"
}

Record 14,693 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.